Inhalation blog posts

11 September, 2017

What's next for inhaled medications and inhalation technology?

By Simon Moore

Current estimates suggest that as many as 235 million people worldwide have asthma and over 200 million people have chronic obstructive pulmonary disease (COPD). With rates set to increase, the need for efficacious medications for these incurable diseases is a major focus for research.

+ Read more

23 June, 2017

Road to Bio: staying the course with a credible partner

By James Smith

It’s that time of the year again when more than 3,500 biotechnology companies, academic institutions, state biotechnology centers and related organizations gather for the BIO International Convention. Nice Insights have invested in one of the world’s fastest vehicles as their mode of transportation to the event in San Diego, CA and have undertaken a 12 day, coast-to-coast road trip – The Road to Bio – mirroring the journey to launching a drug and emphasizing the key component of speed-to-market. Along the way, Nice Insights met with Envigo's very own Joseph Bedford, Ph.D., Corporate Vice President of Strategic Marketing, to discuss Envigo's consultative approach to helping customers reach their development milestones.

Watch the full interview here!

+ Read more

23 April, 2017

How to save $5 million on an inhalation toxicity study

By George Kerrick

A primary objective of any Contract Research Organization (CRO) is to conduct all inhalation studies using the most efficient test article delivery methods available in order to contain and minimize the cost of preclinical product testing. By providing the correct equipment and methods in test article, a recent study saved an estimated $5,000,000 – savings that were substantially greater than the price of the actual study. There are numerous factors to consider when conducting an inhalation study and by considering the following criteria will ensure you maximise the effectiveness of delivering the test article whilst reducing costs where possible. + Read more